Aspect Medical Systems
Brain monitoring systems for measuring consciousness levels
About Aspect Medical Systems
In 1987, Nassib G. Chamoun founded Aspect Medical Systems with a transformative idea for the operating room. The company set out to solve a fundamental challenge in anesthesia: objectively measuring a patient's level of consciousness. For years, anesthesiologists relied on indirect vital signs, but Aspect aimed to provide a direct window into the brain's response to anesthetic drugs. The company's breakthrough was the Bispectral Index (BIS), a technology that processes complex EEG signals into a single, understandable number. After receiving FDA clearance in 1996, the BIS system gave clinicians a reliable way to gauge the depth of sedation, helping to prevent cases of anesthesia awareness and allowing for more precise drug dosage. This innovation established a new standard of care in operating rooms worldwide. A significant milestone occurred on January 28, 2000, when Aspect Medical Systems went public on the NASDAQ. This event provided the capital to expand its reach and further develop the BIS technology. The company also pursued a successful OEM strategy, embedding its BIS modules into the patient monitors of major manufacturers like GE Healthcare and Philips. The final chapter of Aspect's independent journey came in November 2009, when it was acquired by the global healthcare company Covidien for approximately $210 million. This acquisition integrated Aspect's pioneering brain monitoring technology into a much larger portfolio of medical devices. Following Covidien's own acquisition by Medtronic in 2015, the BIS technology continues to be a key tool in anesthesia, a testament to the lasting impact of Chamoun's original vision.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Open positions
- None listed
- Dealroom signal
- 19.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Biotechnology, Oncology
- Business model
- Manufacturing
- Client focus
- B2C
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Sep 2009 | $210M | $210M | Covidien | — |
| IPO✓Exit | Jan 2000 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Aspect Medical Systems is 40 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Aspect Medical Systems in the Minneapolis ecosystem
The Aspect Medical Systems office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later9 investors entered at this stage
Highland Capital Partners
New Venture Partners
The Hillman Company
Charles River Laboratories International- HCHLM Management Company
T. Rowe Price
Invesco
Polaris Partners
OneLiberty Ventures
Other known investors1 additional known investor
Covidien
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aspect Medical Systems on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aspect Medical Systems’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









